Mink Therapeutics Inc
(INKT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2017 | 12-2006 | 09-2002 | 09-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 299 | N/A | N/A | N/A | N/A |
| Other current assets | 532 | 0 | 0 | 5,530 | 5,910 |
| TOTAL | $918 | $N/A | $N/A | $5,530 | $5,910 |
| Non-Current Assets | |||||
| PPE Net | 391 | N/A | N/A | N/A | N/A |
| Investments And Advances | 0 | 0 | 0 | 330 | 1,380 |
| Other Non-Current Assets | 0 | 0 | 0 | 20,530 | 392,750 |
| TOTAL | $391 | $N/A | $N/A | $20,860 | $394,130 |
| Total Assets | $1,309 | $N/A | $N/A | $26,390 | $400,040 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,627 | 0 | 0 | 10,020 | 7,970 |
| Accrued Expenses | 2,601 | N/A | N/A | 30,180 | 58,640 |
| Other current liabilities | N/A | N/A | N/A | 26,760 | 34,610 |
| TOTAL | $7,419 | $N/A | $N/A | $98,170 | $105,190 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 191 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 30,224 | 0 | 0 | 180 | 280 |
| TOTAL | $30,224 | $N/A | $N/A | $390 | $1,690 |
| Total Liabilities | $37,643 | $N/A | $N/A | $98,560 | $106,880 |
| Shareholders' Equity | |||||
| Common Shares | 0 | N/A | N/A | 160 | 120 |
| Retained earnings | -36,496 | N/A | N/A | N/A | N/A |
| Other shareholders' equity | -133 | 0 | 0 | -3,310 | -23,360 |
| TOTAL | $-36,334 | $N/A | $N/A | $949,450 | $874,000 |
| Total Liabilities And Equity | $1,309 | $0 | $0 | $1,048,010 | $980,880 |